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The information on the inhibitory effect of propafenone in vascular
smooth muscle is sparse. Propafenone acts through blockage of
voltage-dependent cardiac Na+ channels, L-type Ca2+ channels,
voltage-sensitive K+ (Kv) channels, as well as -adrenergic receptors in
the heart. The introduction of different chemical groups in the benzyl
moiety of propafenone influences pharmacological properties of newly
developed derivate of propafenone. Here we investigated the effect of
new ortho-chloro derivate of propafenone (5OCl) on the vascular tone
of precontracted rat aorta. 5OCl produced endothelium-independent
relaxation of rat aorta. In order to test the involvement of different ion
channels in 5OCl mechanism of action, antagonist of Na+, lidocaine, KV
channels, 4-aminopyiridine (4-AP) and L-type Ca2+ channels,
nifedipine were used. All tested antagonists of ion channels did not
influence the relaxation of rat aorta induced by high a concentration of
5OCl (10 M), but antagonized the relaxation induced by low
concentrations of this propafenone derivate. Thus, 5OCl derivate has
comparable potency and efficacy as propafenone. According to its
interaction with lidocaine, 4-AP and nifedipine it seems that 5OCl partly
shares the mechanism of action with propafenone. The mechanism of
vasodilatation induced by high micromolar concentration of 5OCl is not
defined and further investigations are necessary.
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INTRODUCTION
Propafenone is a class Ic antiarrhythmic drug used to maintain sinus rhythm
in patients with supraventricular tachycardia, including atrial fibrillation (Goodman
and Gilman, 2003). Propafenone acts through blockage of voltage-dependent
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may also inhibit the L-type Ca2+ channels, K+ channels, as well as -adrenergic
receptors in the heart (Malfatto et al., 1988; Bryson et al., 1993; Franqueza et al.,
1998). The information on the inhibitory effect of propafenone in vascular smooth
muscle is sparse.
Perez-Vizcaino et al. (1994) have shown that propafenone inhibited
contractions of rat aorta and porcine coronary artery which could be attributed to
reduced Ca2+ entry. A decrease in systemic vascular resistance may reduce
ventricular afterload, while a decrease in coronary vascular resistance might
increase coronary blood flow. Thus, it is possible that in some patients these
vasodilatator actions of propafenone may improve the cardiac performance,
overriding its cardiodepressant effect. A possible role for Na+ channel inhibition in
the observed inhibitory effect of propafenone was excluded. Propafenone
decreased the contraction of rat aorta induced by high KCl due to its L-type Ca2+
channel blocking properties (Fernandez del Pozo et al., 1996). In contrast to this,
in the same blood vessel, propafenone inhibited the vasodilatation induced by K+
channel opener, levcromakalim in a non-competitive manner. The concentration
at which this effect was observed within the therapeutic range and similar to the
one reported to inhibit ATP-sensitive K+ (KATP) channels (Cogolludo et al., 1998).
Later, the same authors have shown that propafenone (10 M) inhibited voltage-
sensitive K+ (KV), big calcium-sensitive K+ (BKCa) and KATP channels in the
isolated smooth muscle cell from rat portal veins (Cogolludo et al., 2001). The
inhibition of K+ channels is expected to produce membrane depolarization,
activation of L-type Ca2+ channels and vasoconstriction (Nelson and Quayle,
1995). However, the intravenous administration of propafenone produced a
transitient and slight fall in systolic blood pressure (Feld et al., 1987). It is possible
that at certain concentrations the direct effect of propafenone on vascular K+
channels may be counteracted by the blockage of L-type Ca2+ channels
(Cogolludo et al., 2001).
It is well known that the presence of different chemical groups in drug's
molecules influenced its potency, selectivity and mechanism of action. The
computer-based analysis of substructures of various response modifiers
suggested secondary amino groups, ethers, carbonyl groups and benzyl groups
in the propafenone as possible pharmacophoric substructures (Chiba et al.,
1995). Thus, we have shown that propafenone and its derivates which were
syntethysed by substitution in the benzyl moiety with -F, -CH3 or CF3 groups on
the ortho or para position produced vasodilatation of rat aorta. Introduction of 5-
ortho-CF3 and 5-para-CH3 group in the benzyl moiety of propafenone molecule
changed its potency and Kv and L-type Ca2+ channels are involved in their
mechanism of action. The introduction of other tested groups in the benzyl moiety
did not influence pharmacological properties of derivates of propafenone in
relation to propafenone. Analogs of propafenone were synthesized with
modifications in the benzyl moiety designed on the basis of the pre structure
property relationship (SPR) and pharmacophoric studies (Ivkovic et al., 2012).
Here we investigated the effect of new ortho-chloro derivate of propafenone
(5OCl) on the vascular tone of rat aorta (Fig. 1). According to great efficacy of
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induced relaxation in isolated rat aortapropafenon in therapy of arrhythmia, the development of new structurally related
propafenone derivates with better clinical profile may be useful in future.
MATERIAL AND METHODS
Assessment of vascular function
Male Wistar rats obtained from the animal facilities of the University of
Belgrade of Medicine faculty were used in all experimental procedures. The study
was approved by the Ethical Committee of Faculty of Medicine, University of
Belgrade. The studies reported in this work have been carried out in accordance
with the Guide for the Care and Use of Laboratory Animals are adopted and
promulgated by the United States National Institutes of Health.
Vascular rings were prepared from the aorta of male Wistar rats, body
weight of 250 – 300 g. The aorta segments were dissected free from connective
tissue. They were cut into rings (3 mm) and mounted between two stainless-steel
triangles in an organ bath containing 10 mL Krebs-Ringer-bicarbonate solution
(mmol/L: NaCl 120, KCl 5, CaCl2 2.5, MgSO4 1.2, NaHCO3 25, KH2PO4 1.2,
glucose 11, T = 37oC, pH = 7.4), aerated with 95% O2 and 5% CO2. One of the
triangles has been attached to a displacement unit allowing fine adjustment of
tension and the other was connected to an isometric transducer (K30; Hugo
Sachs, Freiburg, Germany). The preparations were allowed to equilibrate for 30
min. We have examined the effects of 5OCl onto the rings with or without
endothelium. After the equilibration period, the presence of functional
endothelium was assessed. Rings were precontracted with phenylephrine
(10 M) and acetylcholine (20 M) was added into the organ bath. In the some
experiments endothelium was removed mechanically. The resting tension was
2 g. The vascular rings were allowed a further 30 min to equilibrate before being
contracted with phenylephrine (10 M).
Contraction of the rat aorta evoked by phenylephrine
Concentration-responsecurveswereobtainedbythecumulativeadditionof
5OCl to ring segments contracted to a stable plateau by adding phenylephrine.
Increasing concentrations of 5OCl has been added only after the previous
concentration had produced equilibrium response. Therefore, the following
protocol was used: 1) contraction to phenylephrine and concentration - response
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Figure 1. Chemical structures of (A) propafenone and (B) its ortho chloro derivate 5OClcurveto5OClfollowedbythreewashes,additionofionchannelblockers(3mM4-
aminopyridine or 1 M nifedipine or 3 mM lidocaine) and 20 min equilibration
period; 2) contraction to phenylephrine and the concentration-response curve to
5OCl.
Statistical analyses
The results are expressed as the means ± standard error (SEM); n refers to
the number of experiments. The concentration of 5OCl producing 50% of its own
maximum response (EC50) was determined for each curve by using a non-linear
least square fitting procedure of the individual experimental data. The pD2 value
was calculated from -log EC50. Responses are expressed as a percentage of the
maximum possible relaxation, i.e., the return of tension to the pre-phenylephrine
level (Emax). All calculations were done by using the computer program Graph
Pad Prism (Graph Pad Software Inc., San Diego, U.S.A.). Statistical difference
between means was determined by Student's t-test and a p value <0.05 was
considered statistically significant.
Drugs
For chemical synthesis of 5OCl derivate the following compounds are used:
2-hydroxyacetophenone, 2-chlorobenzaldehyde, epichlorhydrine, propylamine,
and hydrochloride acid (Sigma-Aldrich Inc., St. Louis, MO, USA).
In pharmacological experiments the following drugs were used:
phenylephrine, acetylcholine, 4-aminopyridine (4-AP), nifedipine, lidocaine
(Sigma-Aldrich Inc., St. Louis, MO, USA). 5OCl was dissolved in distilled water.
Nifedipine was dissolved in 70% v/v ethanol with further dilution in distilled water
before use. Working concentrations of ethanol in the bath were <0.01% (v/v).
Previous experiments showed that the solvents used had no effects on
preparations at the applied concentrations. All drugs were added directly to the
bath in a volume of 100 L and the concentrations given are the calculated final
concentrations in the bath solution. The experiments with nifedipine were
performed in a dark room.
RESULTS
Synthesis of phenylpropiophenone derivative
Synthesis of the 5OCl compound was carried out according to the general
method first reported by Ivkovic et al., (2009) and its structure has been verified by
NMR, MS and MS spectroscopy. The tested compound is derivative of
phenylpropiophenone (as well as propafenone) with chloro substituent on the
ortho position of the benzyl moiety (Fig. 1). Because of the high structural
similarity between newly synthesized compound and propafenone, this
compound may be considered derivatives of propafenone.
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phenylephrine
5OCl (1 - 100 M) induced a concentration dependent relaxation of rings
with endothelium and without endothelium with EC50 values of 13.51 ± 0.09 M
(Emax = 86.1 ± 3.9%, n = 6) and 14.20 ± 0.10 M( E max = 90.1 ± 2.8%, n = 6)
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Figure 2. Cumulative concentration-response curves to 5OCl in the rat aorta with
endothelium (black circle) and without endothelium (white circle) precontracted with
phenylephrine (10 ìM). Responses are expressed as a percentage of the maximum
possible relaxation (i.e., return to baseline tension). Each point represents the mean
± S.E.M. (n = 12)
Figure 3. Antagonism of the relaxation effects of 5OCl by 4-AP , nifedipine and lidocaine on
tension development in the rat aorta ring. Concentration-response curves for 5OCl in
the absence (open circle) and presence of 4-AP (3 mM, open diamond), nifedipine
(1 M, open triangle) and lidocaine (3 mM, open square). Each point represents the
mean ±S.E.M. (n = 4-7)respectively (p>0.05, Fig. 2). Regarded EC50 values, 4-AP (3 mM,n=7 )d i dn o t
modify the 5OCl induced-relaxation of the rat aorta (EC50 = 16.60 ± 0.1 M,
Emax= 91.1 ± 3.5 %, p> 0.05). Further, nifedipine (1 M ,n=4 )d i dn o tmodify the
relaxation of the rat aorta induced by 5OCl (EC50 = 20.25 ± 0.30 M, Emax =
92.0 ± 4.5 %, p>0.05). Lidocaine (3 mM, n = 6) did not modify the 5OCl induced
relaxation of the aorta rings (EC50 = 13.92 ± 0.11 M, Emax = 97.2 ± 2.5 %,
p<0.05). However, 4-AP , nifedipine and lidocaine significantly inhibited the
relaxation elicited with concentration of 5OCl less than 10 M (EC25 without
antagonist was 5.34 ± 0.11 M; in the presence of 4-AP , nifedipine and lidocaine
EC25 were 5.07 ± 0.14 M, 4.93 ± 0.18 M and 4.99 ± 0.09 M, respectively,
p<0.05, Fig. 3)
4 - AP (3 mM), nifedipine (1 M) and lidocaine (3 mM), did not affect the
basal tension of aorta nor the contraction induced by phenylephrine (data not
shown,n=3-7 ) .
DISCUSSION
5OCl induced endothelium-independent relaxation of rat aorta. This result is
consistent with previous findings for propafenone-induced dilatation of rat aorta
and portal vein (Carron et al., 1991; Cogolludo et al., 1998). Also, we have shown
previously that five newly developed phenylpropiophenone derivate produced
endothelium-independent relaxation of rat aorta (Ivkovic et al., 2012), as well. The
potency of 5OCl (4.85) calculated from the pD2 value from the concentration-
response curves was significantly lower than the potency of propafenone (5.03)
and its derivates, ortho-CF3 (5.12) and ortho-CH3 (4.96) (Ivkovic et al., 2012). It is
obvious that the presence of different chemical groups in the molecule of
propafenone influences its potency.
In order to test the involvement of different ion channels in 5OCl mechanism
of action, antagonist of Na+,K V and L-type Ca2+ channels were used.
To analyze the contribution of Na+ channels to the 5OCl-induced relaxation
of the rat aorta, lidocaine was used. Lidocaine is the local anesthetic that blocks
Nav1.5 channels and has been used therapeutically to manage cardiac arrithmias
(Glaaser and Clancy, 2006). Our data suggest the involvement of lidocaine-
sensitive channels in the relaxation of the rat aorta by 5OCl (if it is used in
concentration lower than 10 M). The rank order of concentration ratio (CR) value
in presence of lidocaine was 0.98. Lidocaine produced a stronger inhibition of the
propafenone effect in the same experimental model (CR = 1.37; Ivkovic et al.,
2012). Lidocaine did not block the effect of higher concentrations of 5OCl
(10 M). It seems that 5OCl has a complex mechanism of action.
To analyze the contribution of K+ channels to the 5OCl-induced relaxation of
the precontracted aorta's ring, we used 4-AP , a blocker of K+ channels (Wulff and
Zhorov, 2008). Used in low milimolar concentratons, 4-AP achieved some
selectivity for Kv channels (O'Rourke, 1996). In this study the CR values of 5OCl
and 4-AP (1.17) was comparable with CR values obtained for ortho-CH3 (1.17)
derivate of propafenone and 4-AP (Ivkovic et al., 2012). In contrast to the results
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channel (Delpon et al., 1995, Duan et al., 1993, Arias et al., 2003). The effect of
propafenone depends on whether the membrane is in a resting potential or in a
state of depolarization (Lemennas - Gruber et al., 1997). Our finding supports a
relavant participation of Kv channels in the relaxation of the aorta ring produced
by 5OCl if it is used in concentrations 10 µM. As propafenone, 5OCl in
concentrations >10 µM acts through Kv channel–independent mechanism of
action (Arias et al., 2003; Ivkovic et al., 2012).
In order to analyze the contribution of the L-type Ca2+ channels to the 5OCl-
induced relaxation of the rat aorta, we used nifedipine. Nifedipine (1 µM) caused
significant antagonism of the effect of = 10 µM 5OCl suggesting the involvement
of the nifedipine-sensitive Ca2+ channels. In rat isolated aortic strips and portal
veins nifedipine inhibited the propafenone effect with similar potency (Carron et
al., 1991; Perez-Vizcaino et al., 1994; Ivkovic et al., 2012). However, we have
shown that nifedipine inhibited more potently the effect of other propafenone
derivate, i.e. ortho-CF3 (Ivkovic et al., 2012). As propafenone, high micromolar
concentrations of 5OCl have ion a channel-independent mechanism of action
(Ivkovic et al., 2012). It has been shown previously that propafenone inhibited
Ca2+ release from intracellular stores in the rat aorta (Carron et al., 1991).
The introduction of Cl group on the ortho position in the bezyl moiety of
propafenone changed its effect on the precontracted rat aorta. 5OCl derivate has
comparable potency and efficacy as propafenone. According to its interaction
with lidocaine, 4-AP and nifedipine it seems that 5OCl partly shares the
mechanism of action with propafenone. The mechanism of vasodilatation
induced by high micromolar concentration of 5OCl is not defined and further
investigations are necessary. But we must be cautious in extrapolating their
results to in vivo conditions.
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induced relaxation in isolated rat aortaRELAKSACIJA AORTE PACOVA INDUKOVANA NOVOSINTETISANIM
ORTO-HLORNIM DERIVATOM PROPAFENONA
IVKOVI] BRANKA, GOJKOVI]-BUKARICA LJILJANA, VLADIMIROV S,
NOVAKOVI] RADMILA, ]UPI] V, LE[I] A, BUMBA[IREVI] M i []EPANOVI] R
SADR@AJ
Informacije o efektima propafenona na vaskularne glatke mi{i}e su os-
kudne. Propafenon blokira volta`no-zavisne Na+ kanale, Ca2+ kanale L-tipa,
volta`no-senzitivne K+ (Kv) kanale i -adrenergi~ke receptore u srcu. Uvo|enje
razli~itih hemijskih grupa u benzilni deo molekula propafenona uti~e na promenu
njegovih farmakolo{kih osobina. U ovoj studiji je ispitivan uticaj novog orto-hloro
derivata (5OCl) propafenona na vaskularni tonus prekontrahovane aorte pacova.
Orto hlorni derivat (5OCl) je izazvao endotel-nezavisnu relaksaciju aortnih prste-
nova.Dabiseispitalaulogarazli~itihjonskihkanalauovojrelaksaciji,kori{}enisu
lidokain,(antagonistNa+kanala),4-aminopiridin(antagonistKvkanala)inifedipin
(antagonist Ca2+ kanala L-tipa). Testirani antagonisti jonskih kanala nisu uticali na
relaksaciju aorte pacova izazvanu visokom koncentracijom 5OCl (10 M), ali su
zato antagonizovali relaksaciju aorte koncentracijama 5OCl koje su bile manje od
10 M. Prema tome, 5OCl derivat ima sli~nu ja~inu i efikasnost kao propafenon.
Prema njegovoj interakciji sa lidokainom, 4-AP i nifedipinom mo`e se re}i da je
mehanizamdejstva5OClsli~anpropafenonu.Mehanizamvazodilatacije5OClde-
rivata u koncentracijama ve}im od 10 M nije definisan i za to su potrebna dalja is-
tra`ivanja.
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